| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Invited Review
1 Department of Physiology, University of Toronto, Toronto, Ontario, Canada M5S 1A8
2 Department of Medicine, Harvard Medical School and Brigham and Women’s Hospital, Boston, Massachusetts 02115
3 Department of Physiology, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas 78284
4 Department of Anatomy and Cell Biology, Queen’s University, Kingston, Ontario, Canada K7L 3N6
ABSTRACT
Melo, Luis G., Mark E. Steinhelper, Stephen C. Pang, Yat Tse, and Uwe Ackermann. ANP in the regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models. Physiol Genomics 3: 45–58, 2000.—The recent development of genetic mouse models presenting life-long alterations in expression of the genes for atrial natriuretic peptide (ANP) or its receptors (NPR-A, NPR-C) has uncovered a physiological role of this hormone in chronic blood pressure homeostasis. Transgenic mice overexpressing a transthyretin-ANP fusion gene are hypotensive relative to the nontransgenic littermates, whereas mice harboring functional disruptions of the ANP or NPR-A genes are hypertensive compared with their respective wild-type counterparts. The chronic hypotensive action of ANP is determined by vasodilation of the resistance vasculature, which is probably mediated by attenuation of vascular sympathetic tone at one or several prejunctional sites. Under conditions of normal dietary salt consumption, the hypotensive action of ANP is dissociated from the natriuretic activity of the hormone. However, during elevated dietary salt intake, ANP-mediated antagonism of the renin-angiotensin system is essential for maintenance of blood pressure constancy, inasmuch as the ANP gene "knockout" mice (ANP -/-) develop a salt-sensitive component of hypertension in association with failure to adequately downregulate plasma renin activity. These findings imply that genetic deficiencies in ANP or natriuretic receptor activity may be underlying causative factors in the etiology of salt-sensitive variants of hypertensive disease and other sodium-retaining disorders, such as congestive heart failure and cirrhosis.
atrial natriuretic peptide; gene knockout; transgenic; renin-angiotensin system; salt-sensitive hypertension; cardiovascular sympathetic tone
This article has been cited by other articles:
|
|
 |
|
  D. Conen, R. J. Glynn, J. E. Buring, P. M Ridker, and R. Y.L. Zee Natriuretic Peptide Precursor A Gene Polymorphisms and Risk of Blood Pressure Progression and Incident Hypertension Hypertension, December 1, 2007; 50(6): 1114 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Buckalew Atrial Peptides Modify the Effect of Marinobufagenin on Sodium Pumps: Implications for Blood Pressure Control Hypertension, December 1, 2006; 48(6): 1029 - 1030. [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Dries, R. G. Victor, J. E. Rame, R. S. Cooper, X. Wu, X. Zhu, D. Leonard, S.-I. Ho, Q. Wu, W. Post, et al. Corin Gene Minor Allele Defined by 2 Missense Mutations Is Common in Blacks and Associated With High Blood Pressure and Hypertension Circulation, October 18, 2005; 112(16): 2403 - 2410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Schillinger, S. Y. Tsai, G. E. Taffet, A. K. Reddy, A. J. Marian, M. L. Entman, K. Oka, L. Chan, and B. W. O'Malley Regulatable atrial natriuretic peptide gene therapy for hypertension PNAS, September 27, 2005; 102(39): 13789 - 13794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Toro, I. Saadi, A. Kuburas, M. Nemer, and A. F. Russo Cell-specific Activation of the Atrial Natriuretic Factor Promoter by PITX2 and MEF2A J. Biol. Chem., December 10, 2004; 279(50): 52087 - 52094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aneja, F. El-Atat, S. I. McFarlane, and J. R. Sowers Hypertension and Obesity Recent Prog. Horm. Res., January 1, 2004; 59(1): 169 - 205. [Abstract] [Full Text]
|
|
|
|
|
|
L. Ying, M. Flamant, S. Vandermeersch, J.-J. Boffa, C. Chatziantoniou, J.-C. Dussaule, and D. Chansel Renal Effects of Omapatrilat and Captopril in Salt-Loaded, Nitric Oxide-Deficient Rats Hypertension, November 1, 2003; 42(5): 937 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Wang, M. G. Larson, D. Levy, E. J. Benjamin, D. Corey, E. P. Leip, and R. S. Vasan Heritability and Genetic Linkage of Plasma Natriuretic Peptide Levels Circulation, July 8, 2003; 108(1): 13 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Peng, B. D. Chambless, S. Oparil, and J. M. Wyss {alpha}2A-Adrenergic Receptors Mediate Sympathoinhibitory Responses to Atrial Natriuretic Peptide in the Mouse Anterior Hypothalamic Nucleus Hypertension, March 1, 2003; 41(3): 571 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Thomas and R. L. Woods Guanylyl Cyclase Receptors Mediate Cardiopulmonary Vagal Reflex Actions of ANP Hypertension, February 1, 2003; 41(2): 279 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Takei and S. Hirose The natriuretic peptide system in eels: a key endocrine system for euryhalinity? Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R940 - R951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Klinger, R. R. Warburton, L. Pietras, P. Oliver, J. Fox, O. Smithies, and N. S. Hill Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H58 - H65. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
